ArticleEuropean journal of clinical investigation2022

Serum levels of VCAM-1 are associated with survival in patients treated with nivolumab for NSCLC.

Federico Carbone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.